Open in interactive viewer → charts, metric popovers & call review

Cineverse Doubled Revenue, Held Guidance — and the Stock Fell 18%

The horror streamer that quietly became a Matchpoint ad-tech platform posted its third straight positive EBITDA quarter. The tape barely noticed.
CNVS · Earnings Call · 2026-11-13

The company that showed up isn't the one that left

On the numbers, Cineverse's fiscal Q2 2027 was a coming-out party. Revenue hit $26 million, and “our revenues increased by 110% versus the prior year” — Chris McGurk, CEO · 2026-11-13, per CEO Chris McGurk. Net income swung to $3.2 million, or $0.11 a share. Adjusted EBITDA was $1.7 million — a $5.4 million year-over-year improvement and, by management's count, the third consecutive positive and growing EBITDA quarter, delivered in the seasonally slowest stretch of the year. But the business underneath those numbers is no longer the one investors bought a few years ago. The doubling was driven by two acquisitions, Giant Worldwide and IndiCue, that turned Cineverse into, in McGurk's framing, a company where “the market is moving towards automation, and we own the best-in-class DVR platform” — Erick Opeka, Executive · 2026-11-13 — a clumsy phrase for Matchpoint, its content-and-advertising automation engine. Ad tech and media services now represent the majority of revenue and growth. To appreciate the scale of the shift, compare it with the prior call, when McGurk said “with these 2 acquisitions, we basically doubled the size of the company” — Christopher J. McGurk, CEO · 2026-08-13. This quarter is the first clean read on what that doubled company looks like.

Guidance held. The tape didn't.

Management reaffirmed full-year fiscal 2027 guidance of $115–$120 million in revenue and $10–$20 million in adjusted EBITDA — the same range it gave after the acquisitions closed. The story is coherent: revenue has inflected, cost discipline is showing, and the back half carries political advertising, holiday shopping, and three theatrical releases. Yet the stock is down roughly 18% over the last 90 days and sits about 23% below its August peak of $2.90, on a market cap near $48 million. The full-history tape is worse — a lifetime return of roughly -99%. For a company whose last filed quarter showed total revenue of about $31 million, up 175% year over year, the valuation disconnect is stark. McGurk offered his own explanation: the film library alone was appraised near $45 million, “more than 7x higher than its current book value” — Chris McGurk, CEO · 2026-11-13 — essentially the entire market cap, with the tech business thrown in for free. Management believes the equity is undervalued; a micro-cap that has burned investors for a decade is a hard sell regardless of the quarter.

The words that changed — and the one that quietly slipped

The most telling shift is linguistic. The top of this quarter's keyword stack is dominated by cost rationalization initiatives and the related cost rationalization program, now expanded to a $14 million annualized target with over $9 million already actioned. On the analyst push about headcount, McGurk was blunt: “We are not adding bodies… we are shifting bodies from the U.S. to lower cost positions in India and Poland and Moldova” — Chris McGurk, CEO · 2026-11-13, pointing at the cost base as the real lever. The board nomination of Dr. Samrat Ganguly — an AI infrastructure entrepreneur and architect of Matchpoint — signals where management wants the narrative to go next.

Since you are a tech company now, why are we adding people and not replacing people with tech platforms?… taking pricing on your subscriptions up by 40% says to me strategically you are getting out of that business

Laura Martin, Analyst · 2026-11-13
Laura Martin's question cuts to the tension precisely: the company wants the multiple of an automation platform while still carrying the labor of a services business and the churn risk of a subscription base it just repriced 25–40%. Meanwhile two themes that dominated prior calls have gone quiet. Micro drama, a top keyword a year ago, is absent entirely. And Vadio — the audio/ad-tech synergy that was the number-one company keyword as recently as fiscal Q3 and the poster child for revenue upside — has been demoted to technical trials, with rollout now guided to fiscal Q4 to January. That is a slide from the prior call, when Erick Opeka said “we gave some steady state guidance for that business at around a $12 million run rate… our hope is to start to see real meaningful contribution out of that business towards the end of this quarter” — Erick Opeka, COO or Head of Operations · 2026-08-13. The quarter came; the contribution didn't yet.

The balance-sheet asterisk

The growth story runs straight into a thin liquidity picture. Cineverse ended the quarter with $3.6 million of cash and negative working capital of $9.7 million, though management notes it can settle $8 million of that in equity. The fundamentals confirm the strain: effective net cash sits around -$7 million, and liabilities-to-assets climbed to 70.4%, up 29 points year over year. Free cash flow, while improving, remains modestly negative at roughly -$2 million. A $3 million BondIt loan was taken against Pan's Labyrinth to smooth theatrical timing. Which makes the loudest announcement of the call the one to watch most closely: a new Jason Voorhees film, the 13th in one of the biggest horror franchises in history, secured with 25-year North American rights. McGurk insists it will be “fully fund it internally with no third-party capital” — Chris McGurk, CEO · 2026-11-13, leaning on producers financing the negative and a de minimis out-of-pocket marketing model. If the last six wide releases, including Pan's Labyrinth, are all profitable as claimed, the film slate is a genuine cash engine. But on $3.6 million of cash, "internally funded" is a promise the balance sheet will be asked to keep.

The bottom line

Cineverse is a real transition story dressed as a disappointing quarter. The revenue is genuinely transformed, EBITDA has turned for three straight quarters, and cost rationalization is measurable rather than aspirational. But the market is pricing the risk that this is still a sub-$50 million company funding a theatrical bet and an automation pivot off a revolver and an equity-settled IOU. The catalysts for the back half are concrete — political ad spend, a subscription repricing the company says is seeing limited churn, and Jason on a Friday the 13th. What is not yet concrete is a quarter where the technology narrative shows up as cash rather than as a press release.